Michael F. Huang, Senior VP of Clinical Development at SOLENO THERAPEUTICS INC (SLNO), sold 13,164 shares at $30.04 ($401K) on 2026-03-27, disclosed to the SEC on 2026-03-31.
Open-market sale of $401k SLNO by Senior VP of Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.04 | 4,256 | $128K | 31.9% |
| 2 | $30.04 | 4,256 | $128K | 31.9% |
| 3 | $31.04 | 1,838 | $57K | 14.2% |
| 4 | $31.04 | 1,838 | $57K | 14.2% |
| 5 | $31.72 | 488 | $15K | 3.9% |
| 6 | $31.72 | 488 |
| $15K |
| 3.9% |
| Total | $30.44 avg | 13,164 | $401K | 100% |